Variant report
Variant | esv3394514 |
---|---|
Chromosome Location | chr2:51742423-51744796 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564925425 | chr2:51743620-51743621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11563001 | chr2:51743632-51743633 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs190451200 | chr2:51743647-51743648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149300391 | chr2:51743671-51743672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76194900 | chr2:51743687-51743688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10495996 | chr2:51743688-51743689 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs556617037 | chr2:51743724-51743725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111228015 | chr2:51743730-51743731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577964272 | chr2:51743773-51743774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371900737 | chr2:51743792-51743793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554503615 | chr2:51743795-51743796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544966454 | chr2:51743806-51743807 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375714013 | chr2:51743808-51743809 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs28958302 | chr2:51743830-51743831 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs13010068 | chr2:51743858-51743859 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs147392594 | chr2:51743869-51743870 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115778803 | chr2:51743941-51743942 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531329911 | chr2:51743957-51743958 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs78513279 | chr2:51744006-51744007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs28958303 | chr2:51744016-51744017 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs532171250 | chr2:51744061-51744062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139818757 | chr2:51744062-51744063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13027868 | chr2:51744098-51744099 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs564069544 | chr2:51744124-51744125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534113680 | chr2:51744132-51744133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549613140 | chr2:51744153-51744154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567734176 | chr2:51744163-51744164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538344790 | chr2:51744167-51744168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543954750 | chr2:51744261-51744262 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145293573 | chr2:51744278-51744279 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577956155 | chr2:51744281-51744282 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574177006 | chr2:51744335-51744336 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539052734 | chr2:51744336-51744337 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553768936 | chr2:51744373-51744374 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543238682 | chr2:51744386-51744387 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs72889236 | chr2:51744388-51744389 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13004892 | chr2:51744402-51744403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542431681 | chr2:51744406-51744407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560754478 | chr2:51744410-51744411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182752036 | chr2:51744423-51744424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369288232 | chr2:51744424-51744425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532787426 | chr2:51744434-51744435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17863616 | chr2:51744446-51744447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531988332 | chr2:51744450-51744451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28958304 | chr2:51744488-51744489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560588694 | chr2:51744508-51744509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11563170 | chr2:51744518-51744519 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs72889237 | chr2:51744534-51744535 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs567867859 | chr2:51744538-51744539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538487387 | chr2:51744558-51744559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51743600-51743800 | Enhancers | HUVEC | blood vessel |
2 | chr2:51743800-51744000 | Flanking Active TSS | HUVEC | blood vessel |
3 | chr2:51744000-51744200 | Enhancers | HUVEC | blood vessel |
4 | chr2:51744200-51744400 | Flanking Active TSS | HUVEC | blood vessel |
5 | chr2:51744400-51744800 | Enhancers | HUVEC | blood vessel |